We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...

Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal 2025 first quarter ended December 31, 2024. The Company is hosting ...

Clinical Trials Market OverviewThe Clinical Trials Market report delivers crucial insights into the market's growth ...

Many Americans with high-deductible health insurance plans face a cold reality at the start of every year. However, patient advocates say there are ways to manage the challenge.

Some researchers believe that body fat percentage provides a more reliable indicator of the potential for obesity-related ...

Spokeo explored the negative impacts of smartphone usage on sleep and what people can do to get more restful downtime.

Today, the American Diabetes Association® (ADA) announced a new suite of resources to support improved care for those living with obesity. The resources are part of a nationwide collaboration between ...

Conference call scheduled for 4:30 p.m. ET today Initiation of Phase 3 Studies for Subcutaneous VK2735 for Obesity Planned for 2Q25 Phase 2 VENTURE-Oral Dosing Trial ...

Erectile Dysfunction Drugs Market 2025 The global market is driven by factors such as an Increase in the prevalence of erectile dysfunction ...

Super Bowl Sunday isn’t here yet, but some of the commercials set to air during the game have already been released.

Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...